Identification of a Novel Saxitoxin Analogue, 12β-Deoxygonyautoxin 3, in the Cyanobacterium, (TA04).

Toxins (Basel)

Graduate School of Agricultural Science, Tohoku University, 468-1 Aramaki-Aza-Aoba, Aoba-ku, Sendai 980-8572, Japan.

Published: September 2019

AI Article Synopsis

Article Abstract

Saxitoxin (STX) and its analogues, the potent voltage-gated sodium channel blockers, are biosynthesized by freshwater cyanobacteria and marine dinoflagellates. We previously identified several biosynthetic intermediates in the extract of the cyanobacterium, (TA04), that are primarily produced during the early and middle stages in the biosynthetic pathway to produce STX. These findings allowed us to propose a putative biosynthetic pathway responsible for STX production based on the structures of these intermediates. In the present study, we identified 12β-deoxygonyautoxin 3 (12β-deoxyGTX3), a novel STX analogue produced by (TA04), by comparing the retention time and MS/MS fragmentation pattern with those of synthetic standards using LC-MS. The presence of this compound in (TA04) is consistent with stereoselective enzymatic oxidations at C11 and C12, and 11--sulfation, during the late stage of STX biosynthesis, as proposed in previous studies.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6784053PMC
http://dx.doi.org/10.3390/toxins11090539DOI Listing

Publication Analysis

Top Keywords

cyanobacterium ta04
8
biosynthetic pathway
8
stx
5
identification novel
4
novel saxitoxin
4
saxitoxin analogue
4
analogue 12β-deoxygonyautoxin
4
12β-deoxygonyautoxin cyanobacterium
4
ta04
4
ta04 saxitoxin
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!